Clinical Trial Update: Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction [Phase 2]

View source ↗

Summary

This Phase 2 trial tested a multimodal regimen including panitumumab with docetaxel, cisplatin, radiation therapy, and surgery for newly diagnosed locally advan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction
• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Panitumumab (panitumumab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-19